Model
Edge
Syros Pharmaceuticals Inc.
SYRS
Filing Type
8-K
Filing Date
2/27/2025
Updated
2/28/25, 2:15 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation, Other Events
EX-99.1
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation, Other Events